UPSC & GPSC · Current Affairs
Medical Innovations Patent Mitra Platform
Source: Indian Council of Medical Research (ICMR)
What’s in News
Recently, the National Medical Commission directed all medical colleges and institutions to utilize the Medical Innovations Patent Mitra Platform developed by the Indian Council of Medical Research to promote innovation, patent protection, and commercialization of healthcare technologies.
Key Facts
- Medical Innovations Patent Mitra (I2I Connect) supports patent filing and technology transfer for innovative biomedical research, with fully government-funded support for strategic and high-quality patent applications.
- It seeks to strengthen India’s healthcare innovation ecosystem by facilitating the transition of research into market-ready products, and enables researchers to protect their Intellectual Property Rights (IPR).
- Launched by ICMR, developed under the guidance of NITI Aayog, and implemented in partnership with the Department of Pharmaceuticals and the DPIIT.
- Objectives: Support patent protection for biomedical innovations, facilitate technology transfer from labs to industry, accelerate commercialization of indigenous medical products, promote collaboration among scientists, researchers, startups and industry, and improve access to affordable healthcare solutions.
- Significance: Encourages a culture of innovation and IP creation in medical institutions, strengthens India’s biomedical research ecosystem, and supports indigenous healthcare technologies under the vision of Atmanirbhar Bharat.
Consider the following statements regarding the Medical Innovations Patent Mitra Platform:
1. It was launched by the Indian Council of Medical Research (ICMR).
2. The platform provides government-funded support for patent filing and technology transfer.
3. It was developed under the guidance of NITI Aayog.
Which of the statements given above is/are correct?
(a) 1 and 2 only
(b) 2 and 3 only
(c) 1 and 3 only
(d) 1, 2 and 3
Answer: (d) 1, 2 and 3
Statement 1 is correct: the platform was launched by ICMR. Statement 2 is correct: it provides fully government-funded support for patent filing and technology transfer. Statement 3 is correct: it was developed under the guidance of NITI Aayog with support from the Department of Pharmaceuticals and DPIIT.
